Swedbank
XENE icon

Swedbank’s Xenon Pharmaceuticals XENE Stock Holding History

Swedbank’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.61M Buy
76,300
+50,100
+191% +$2.78M ﹤0.01% 590
2026
Q1 		$1.52M Buy
+26,200
New +$1.21M ﹤0.01% 648

Other funds holding XENE

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Swedbank's XENE Position: Q2 2026 in Review

Swedbank increased its Xenon Pharmaceuticals (XENE) stake by 191% in Q2 2026, buying an estimated $2.78M and bringing the position to 76,300 shares worth $4.61M. The position accounts for ﹤0.01% of the portfolio, ranked #590.

Swedbank first reported a position in XENE in Q1 2026 and has held it in 2 quarters since. 52 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Swedbank held 76,300 shares of Xenon Pharmaceuticals worth $4.61M as of Q2 2026.
  • Swedbank bought 50,100 Xenon Pharmaceuticals shares in Q2 2026, an estimated $2.78M.
  • Xenon Pharmaceuticals made up ﹤0.01% of Swedbank's portfolio in Q2 2026, its #590 holding.
  • Swedbank first reported a position in Xenon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 52 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.